ISDA

Deposition Date 2007-03-22

Release Date 2007-05-08

Last Version Date 2024-11-06

Entry Detail

PDB ID:

2UWO

Keywords:

HYDROLASE

Title:

Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.75 Å

R-Value Free:

0.25

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:COAGULATION FACTOR X
Gene (Uniprot):F10
Chain IDs:A
Chain Length:254
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Protein Blast

Polymer Type:polypeptide(L)
Molecule:COAGULATION FACTOR X
Gene (Uniprot):F10
Chain IDs:B
Chain Length:134
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Ligand Molecules

701

Primary Citation

Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa.

Young, R.J, Brown, D, Burns-Kurtis, C.L, Chan, C, Convery, M.A, Hubbard, J.A, Kelly, H.A, Pateman, A.J, Patikis, A, Senger, S, Shah, G.P, Toomey, J.R, Watson, N.S, Zhou, P.Show

Bioorg.Med.Chem.Lett. 17 2927 ? (2007)

PMID: 17420122 DOI: 10.1016/J.BMCL.2007.03.080

Abstact

The synthetic entry to new classes of dual fXa/thrombin and selective thrombin inhibitors with significant oral bioavailability is described. This was achieved through minor modifications to the sulfonamide group in our potent and selective fXa inhibitor (E)-2-(5-chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-(morpholin-4-yl)-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide and these observed activity changes have been rationalised using structural studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures